Citarinostat (ACY241) is a second generation potent, orally active and high-selective HDAC6 inhibitor with an IC50 of 2.6 nM (IC50s of 35 nM, 45 nM, 46 nM and 137 nM for HDAC1, HDAC2, HDAC3 and HDAC8, respectively). Citarinostat has anticancer effects[1]
Molecular Weight:
467.95
Purity:
99.30
CAS Number:
[1316215-12-9]
Formula:
C24H26ClN5O3
Target:
HDAC
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
